AAAAAA

   
Results: 1-16 |
Results: 16

Authors: FURLAN J SMOLE F POPOVIC P TOPIC M KAMIN M
Citation: J. Furlan et al., CHARGE-CARRIER TRANSPORT IN N-I-P AND P-I-N A-SI C-SI HETEROJUNCTION SOLAR-CELLS/, Solar energy materials and solar cells, 53(1-2), 1998, pp. 15-21

Authors: HARATI Y GOOCH C SWENSON M EDELMAN S GREENE D RASKIN P DONOFRIO P CORNBLATH D SACHDEO R SIU CO KAMIN M
Citation: Y. Harati et al., DOUBLE-BLIND RANDOMIZED TRIAL OF TRAMADOL FOR THE TREATMENT OF THE PAIN OF DIABETIC NEUROPATHY, Neurology, 50(6), 1998, pp. 1842-1846

Authors: YERBY MS ANNEGERS JF BRUNI J CRAGAN J HOLMES L JACOBS M MITTENDORF R BRANDENBURG N CARROLL M FIFE D FORD L KAMIN M LUSCOMB F NABULSI A TENNIS P
Citation: Ms. Yerby et al., A NORTH-AMERICAN REGISTRY FOR EPILEPSY AND PREGNANCY, A UNIQUE PUBLICPRIVATE PARTNERSHIP OF HEALTH SURVEILLANCE/, Epilepsia, 39(7), 1998, pp. 793-798

Authors: KAMIN M CAZZANIGA EK RAINA MK SHANK RP
Citation: M. Kamin et al., UNTITLED, Epilepsia, 39(2), 1998, pp. 232-232

Authors: SACKELLARES JC KAMIN M
Citation: Jc. Sackellares et M. Kamin, ONSET OF ANTICONVULSANT EFFECT OF TOPIRAMATE, A NEW ANTIEPILEPTIC DRUG (AED), Neurology, 48(3), 1997, pp. 1037-1037

Authors: EDWARDS KR KAMIN M
Citation: Kr. Edwards et M. Kamin, THE BENEFICIAL EFFECT OF SLOWING THE INITIAL TITRATION RATE OF TOPIRAMATE, Neurology, 48(3), 1997, pp. 1042-1042

Authors: KAMIN M ABOUKHALIL B
Citation: M. Kamin et B. Aboukhalil, LONG-TERM EFFICACY OF TOPIRAMATE, Neurology, 48(3), 1997, pp. 43005-43005

Authors: FAUGHT E KUZNIECKY RI GILLIAM F KAMIN M
Citation: E. Faught et al., COGNITIVE ADVERSE-EFFECTS OF TOPIRAMATE, Neurology, 48(3), 1997, pp. 43006-43006

Authors: SCHNITZER T KAMIN M
Citation: T. Schnitzer et M. Kamin, ULTRAM(R) (TRAMADOL HCL) MAINTAINS RELIEF OF OSTEOARTHRITIS (OA) PAINWHEN SUBSTITUTED FOR HIGH-DOSE NAPROXEN, Arthritis and rheumatism, 40(9), 1997, pp. 335-335

Authors: BITON V REIFE R KAMIN M BOBROSKY K
Citation: V. Biton et al., TOPIRAMATE (TOPAMAX) AS ADD-ON THERAPY FOR PATIENTS WITH PRIMARY GENERALIZED EPILEPSY, Neurology, 46(2), 1996, pp. 2024-2024

Authors: DEVINSKY O FAUGHT RE WILDER BJ KANNER AM KAMIN M KRAMER LD ROSENBERG A
Citation: O. Devinsky et al., EFFICACY OF FELBAMATE MONOTHERAPY IN PATIENTS UNDERGOING PRESURGICAL EVALUATION OF PARTIAL SEIZURES, Epilepsy research, 20(3), 1995, pp. 241-246

Authors: ADUSUMALLI VE WICHMANN JK KUCHARCZYK N KAMIN M SOFIA RD FRENCH J SPERLING M BOURGEOIS B DEVINSKY O DREIFUSS FE KUZNIECKY RI FAUGHT E ROSENFELD W
Citation: Ve. Adusumalli et al., DRUG CONCENTRATIONS IN HUMAN BRAIN-TISSUE SAMPLES FROM EPILEPTIC PATIENTS TREATED WITH FELBAMATE, Drug metabolism and disposition, 22(1), 1994, pp. 168-170

Authors: RITTER FJ LEPPIK IE DREIFUSS FE RAK I SANTILLI N HOMZIE R DODSON WE GLAUSER TA SACKELLARES JC OLSON L GARAFOLO EA SHIELDS WD FRENCH J SPERLING M KRAMER LD KAMIN M ROSENBERG A SHUMAKER R PERHACH JL DIX R
Citation: Fj. Ritter et al., EFFICACY OF FELBAMATE IN CHILDHOOD EPILEPTIC ENCEPHALOPATHY (LENNOX-GASTAUT SYNDROME) (REPRINTED FROM NEW-ENGLAND JOURNAL OF MED, VOL 328, PG 29, 1993), Hospital formulary, 28, 1993, pp. 29-36

Authors: FAUGHT E SACHDEO RC REMLER MP CHAYASIRISOBHON S IRAGUIMADOZ VJ RAMSAY RE SUTULA TP KANNER A HARNER RN KUZNIECKY R KRAMER LD KAMIN M ROSENBERG A
Citation: E. Faught et al., FELBAMATE MONOTHERAPY FOR PARTIAL-ONSET SEIZURES - AN ACTIVE-CONTROL TRIAL, Neurology, 43(4), 1993, pp. 688-692

Authors: BOURGEOIS B LEPPIK IE SACKELLARES JC LAXER K LESSER R MESSENHEIMER JA KRAMER LD KAMIN M ROSENBERG A
Citation: B. Bourgeois et al., FELBAMATE - A DOUBLE-BLIND CONTROLLED TRIAL IN PATIENTS UNDERGOING PRESURGICAL EVALUATION OF PARTIAL SEIZURES, Neurology, 43(4), 1993, pp. 693-696

Authors: KRAMER LD PLEDGER GW KAMIN M
Citation: Ld. Kramer et al., PROTOTYPE ANTIEPILEPTIC DRUG CLINICAL DEVELOPMENT PLAN, Epilepsia, 34(6), 1993, pp. 1075-1084
Risultati: 1-16 |